Danaher Corporation (DHR)

NYSE: DHR · USD

$197

+5.00 (+2.6%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-07-28 02:00 UTC. Latest published research analyzed 2026-05-10 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh DHR analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-10

Our latest published analysis: DHR rated Hold

DHR is rated Hold at $171.16 versus the reconciled fair value midpoint of $163.10, implying -4.71% upside/downside. Confidence is separately disclosed at 87/100.

Fair value (mid)

$163 / share

$123 – $204

Upside to FV

-4.7%

from $197

Confidence

87/100

Moat

9/10

Read full analysis

Market cap	$121.1B
Revenue (ttm)	25.1B
Net income (ttm)	4B
EPS (ttm)	$5.63
Shares out	703M
P/E (trailing)	35.0x
P/E (forward)	18.8x
Dividend	$1.60 (0.81%)
Volume	5,340,634
Beta	0.82
Price target	$228	+15.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 25.1B
Net income (ttm): 4B
EPS (ttm): $5.63
P/E (trailing): 35.0x
P/E (forward): 18.8x
Market cap: $121.1B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$24.80B	$26.64B	$23.89B	$23.88B	$24.57B	-0.2%
Gross profit	$15.24B	$16.19B	$14.03B	$14.21B	$14.52B	-1.2%
Operating income	$6.39B	$7.54B	$5.20B	$4.86B	$4.69B	-7.4%
Net income	$6.43B	$7.21B	$4.76B	$3.90B	$3.61B	-13.4%
EPS (diluted)	—	$9.66	$6.38	$5.29	$5.05	-15.0%
EBITDA	$8.80B	$9.48B	$7.50B	$7.28B	$6.95B	-5.8%
R&D	$1.50B	$1.53B	$1.50B	$1.58B	$1.60B	+1.6%
SG&A	$6.81B	$7.12B	$7.33B	$7.76B	$8.24B	+4.9%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	41.0x	11.0x	104.3%	+6.8%	+58.6%	Sell
ABNB	Airbnb Inc.	90.8B	37.5x	7.2x	15.9%	+29.9%	+7.6%	Hold
ADBE	Adobe Inc.	104.7B	15.1x	4.2x	60.7%	+11.9%	-28.7%	Strong Buy
ABBV	AbbVie Inc.	465.2B	129.7x	7.4x	14.4%	+4.6%	+44.0%	Hold
ABT	Abbott Laboratories	186.9B	34.9x	4.0x	7.9%	+3.0%	-12.5%	Strong Buy
AMGN	Amgen Inc.	209.2B	27.0x	5.6x	19.1%	+8.1%	+32.5%	Strong Buy

All DHR indicators

Market & fundamental data

Available fields

292

Groups with data

Currency

USD

Showing 292 of 292 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000313616
Company name	Danaher Corporation
Country	United States
Country code	US
Cusip	235851102
Employees	60,000
Employees Change	-3,000%
Employees Change Percent	-4.76
Enterprise value	$161.6B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Diagnostics & Research
Industry PE	43.06
Industry PE Fwd	25.8
Isin	US2358511028
Last refreshed	2026-07-28
Market cap	$138.1B
Market cap category	Large-Cap
Price	$197
Price currency	USD
Rev Per Employee	418,450x
Sector	Healthcare
Sector PE	45.29
Sector PE Fwd	23.97
Sic	3823
Symbol	DHR
Website	https://www.danaher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.9%
EV Earnings	40.37x
EV Sales Forward	5.85x
EV/EBIT	31.53x
EV/EBITDA	21.11x
EV/FCF	29.57x
EV/Sales	6.44x
FCF yield	3.96%
Forward P/E	22.19x
P/B ratio	2.63x
P/E ratio	35x
P/S ratio	5.5x
PE Ratio10 Y	34.19x
PE Ratio3 Y	39.98x
PE Ratio5 Y	36.42x
PEG ratio	2.52x
PS Forward	4.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.42%
EBITDA Margin	30.5%
FCF margin	21.77%
Gross margin	58.75%
Gross Profit	$14.8B
Gross Profit Growth	2.87%
Gross Profit Growth Q	3.8%
Gross Profit Growth3 Y	2.39%
Gross Profit Growth5 Y	-1.89%
Net Income	$4B
Net Income Growth	17.32%
Net Income Growth Q	56.76%
Net Income Growth Quarters	4%
Net Income Growth Years	0%
Net Income Growth3 Y	-14%
Net Income Growth5 Y	-5.97%
Pretax Margin	18.97%
Profit Margin	15.95%
Profit Per Employee	$66,733
Profitable Quarters	$97
Profitable Years	33
ROA	3.95
Roa5y	4.66
ROCE	6.08
ROE	7.6
Roe5y	9.78
ROIC	6.44
Roic5y	8.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.14%
Cagr15y	12.96%
Cagr1y	-3.67%
Cagr20y	12.14%
Cagr3y	-5.22%
Cagr5y	-4.78%
Div CAGR10	9.33%
Div CAGR3	11.46%
Div CAGR5	13.05%
EPS Growth	19.57
EPS Growth Q	59.74
EPS Growth Quarters	4
EPS Growth Years	0
EPS Growth3 Y	-12.88
EPS Growth5 Y	-5.6
FCF Growth	12.42%
FCF Growth Q	16.06%
FCF Growth3 Y	-9.01%
FCF Growth5 Y	-4.49%
OCF Growth	7.55%
OCF Growth Q	14.65%
OCF Growth10 Y	4.58%
OCF Growth3 Y	-7.65%
OCF Growth5 Y	-3.52%
Revenue Growth	4.56x
Revenue Growth Q	5.54x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	2.87x
Revenue Growth5 Y	-1.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.29
Assets	$92.4B
Cash	$4.3B
Current Assets	$13.4B
Current Liabilities	$8.1B
Debt	$27.9B
Debt EBITDA	$3.64
Debt Equity	$0.53
Debt FCF	$5.1
Equity	$52.6B
Interest Coverage	17.56
Liabilities	$39.8B
Long Term Assets	$79B
Long Term Liabilities	$31.7B
Net Cash	$-23.5B
Net Cash By Market Cap	$-17.02
Net Debt EBITDA	$3.07
Net Debt Equity	$0.45
Net Debt FCF	$4.3
Tangible Book Value	$-16.2B
Tangible Book Value Per Share	$-23.03
WACC	7.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.65
Inventory Turnover	3.48
Net Working Capital	$2.3B
Quick ratio	1.15
Working Capital	$5.3B
Working Capital Turnover	$5.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.87%
Dividend Growth	22.03%
Dividend Growth Years	8%
Dividend per share	$1.6
Dividend Years	34
Dividend Yield	0.81%
Ex Div Date	2026-06-26
Last Dividend	$0.4
Payout Frequency	Quarterly
Payout Ratio	25.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	187.6%
1Y total return	-3.66%
200-day SMA	203.9
3Y total return	-14.87%
50-day SMA	185.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-21.72%
All Time High	334
All Time High Change	-41.16%
All Time High Date	2021-09-10
All Time Low	0
All Time Low Change	9,824,900%
All Time Low Date	1977-06-17
ATR	7.36
Beta	0.82
Beta1y	0.72
Beta2y	0.76
Ch YTD	-14.16
High	196.6
High52	242.8
High52 Date	2026-01-22
High52ch	-19.07%
Low	189.9
Low52	160.9
Low52 Date	2026-05-15
Low52ch	22.1%
Ma50ch	6.17%
Premarket Change Percent	0.26
Premarket Price	$192
Premarket Volume	2,354
Price vs 200-day SMA	-3.61%
RSI	54.38
RSI Monthly	43.65
RSI Weekly	50.98
Sharpe ratio	-0.05x
Sortino ratio	0.11
Total Return	2.69%
Tr YTD	-13.8
Tr15y	521.93%
Tr1m	0.16%
Tr1w	-2.29%
Tr3m	11.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	26
Analyst Count Top	11
Analyst Price Target Top	$218
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$1.84
Earnings EPS Estimate Growth	2.22
Earnings Revenue Estimate	6,106,306,664x
Earnings Revenue Estimate Growth	2.87x
Operating Income	$5.5B
Operating Income Growth	6.2
Operating Income Growth Q	3.77
Operating Income Growth3 Y	-2.13
Operating Income Growth5 Y	-5.1
Operating margin	21.89
Price target	$228
Price Target Change	$15.83
Price Target Change Top	$10.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	625,842,794%
Float Percent	89.03%
Net Borrowing	9,836,000,000
Shares Insiders	10.86%
Shares Institutions	83.77%
Shares Out	702,986,054
Shares Qo Q	-0.51%
Shares Yo Y	-1.87%
Short Float	1.61%
Short Ratio	2.46
Short Shares	1.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$5.2B
Adjusted OCF	6,338,000,000
Average Volume	6,008,156.7x
Bv Per Share	74.81
CAPEX	$-1.2B
Ch10y	142.2
Ch15y	289.9
Ch1m	0.16
Ch1w	-2.29
Ch1y	-4.37
Ch20y	514.3
Ch3m	10.86
Ch3y	-25.81
Ch5y	-32.28
Ch6m	-16.99
Change	2.61%
Change From Open	2.67
Close	191.5
Days Gap	-0.06
Depreciation Amortization	2,531,000,000
Dollar Volume	1,049,434,581
Earnings Date	2026-07-21
Earnings Time	bmo
EBIT	$5.1B
EBITDA	$7.7B
EPS	$5.63
F Score	5
FCF	$5.5B
FCF EV Yield	3.38x
FCF Per Share	$7.78
Financing CF	5,860,000,000
Fiscal Year End	December
Founded	1,969
Goodwill	47,414,000,000
Graham Number	97.38499
Graham Upside	-50.44
Income Tax	$772M
Investing CF	-11,092,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-21
Last Report Date	2026-06-26
Last Split Date	2010-06-14
Last Split Type	Forward
Last10k Filing Date	2026-02-24
Lynch Fair Value	$28.17
Lynch Upside	-85.66
Ma150	198.8
Ma150ch	-1.16%
Ma20	194.9
Ma20ch	0.84%
Net CF	1,391,000,000
Next Earnings Date	2026-10-20
Open	191.4
Optionable	Yes
P FCF Ratio	25.27
P FCF Ratio SBC	26.72
P OCF Ratio	20.82
P OCF Ratio SBC	21.8
Payment Date	2026-07-31
Position In Range	98.08
Post Close	196.5
Postmarket Change Percent	-0.48
Postmarket Price	$196
Ppne	7,025,000,000
Pre Close	191.5
Price Date	2026-07-27
Price EBITDA	$18.04
Relative Volume	0.89x
Revenue	25,107,000,000x
SBC By Revenue	1.18x
Share Based Comp	297,000,000
Tax By Revenue	3.07x
Tax Rate	16.21%
Tr20y	888.12%
Tr6m	-16.64%
Us State	District of Columbia
Volume	5,340,634
Z Score	3.45

Frequently asked questions

About this DHR report

What is the latest published DHR stock rating?

Danaher Corporation is shown with hold in the latest published report, analyzed 2026-05-10. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full DHR analysis?

The full latest published report, analyzed 2026-05-10, lives at /stocks/DHR/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for DHR?

The latest published report analyzed 2026-05-10 frames DHR around USD 123 to USD 204. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the DHR page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-10). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Danaher Corporation (DHR)

Coverage state: Latest published research available

Generate a fresh DHR analysis

Our latest published analysis: DHR rated Hold

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · DHR

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All DHR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on DHR

Frequently asked questions